Article
Federal Circuit Finds Claims Directed To Host Cells Patent-Eligible
On February 20, 2026, the Federal Circuit held that patent claims directed to a cultured host cell are patent-eligible under 35 U.S.C. § 101—reversing a district court's January 2024 decision granting summary judgment of patent ineligibility.
Goodwin Procter LLP